[{"id":"5e378d93-e9ca-43aa-9e40-63cbd90717a2","acronym":"","url":"https://clinicaltrials.gov/study/NCT02977689","created_at":"2021-01-18T14:38:23.894Z","updated_at":"2025-02-25T15:53:35.551Z","phase":"Phase 2","brief_title":"Trial of IDH305 in IDH1 Mutant Grade II or III Glioma","source_id_and_acronym":"NCT02977689","lead_sponsor":"NYU Langone Health","biomarkers":" IDH1","pipe":" | ","alterations":" IDH1 mutation • IDH1 R132","tags":["IDH1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IDH1 mutation • IDH1 R132"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IDH305"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 04/01/2018","start_date":" 04/01/2018","primary_txt":" Primary completion: 04/01/2020","primary_completion_date":" 04/01/2020","study_txt":" Completion: 04/01/2020","study_completion_date":" 04/01/2020","last_update_posted":"2017-12-20"}]